HTG Molecular Diagnostics Stock News

Veteran Drug Developer Stephen Barat, Ph.D. Joins to Head Company's Therapeutics Division Veteran Drug Developer Stephen Barat, Ph.D. Joins to Head Company's Therapeutics Division

TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that comp

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q2 2021 Results - Earnings Call Transcript

Call scheduled for today, August 12, at 4:30pm ET Call scheduled for today, August 12, at 4:30pm ET

HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the  HTG EdgeSeq technology

TUCSON, Ariz., July 23, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that, on J

The stock price of HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) increased by 7.34% yesterday. This is why it happened.

TUCSON, Ariz., May 24, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that its HT

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2021 Results - Earnings Call Transcript

TUCSON, Ariz., May 04, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will repo

TUCSON, Ariz., April 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported certain pr

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2020 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TUCSON, Ariz., March 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will re

Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition o